logo

For the Inventor, By the Inventor

San Carlos, CA, United States of America

Steven H Krawczyk

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignee: Gilead Sciences, Inc.. Active years: 1998-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven H Krawczyk. Retrieved from https://idiyas.com/inventor/steven-h-krawczyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 71.4

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 190(Granted Patents)


Location History:

  • San Carlos, CA (US) (1998 - 2008)
  • Palo Alto, CA (US) (2009 - 2010)

Company Filing History:

goldMedal7 out of 948 
 
Gilead Sciences, Inc.
 patents

Years Active: 1998-2010

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7645747 - Therapeutic phosphonate compounds (2010-01-12),
2. 7579332 - Nucleobase phosphonate analogs for antiviral treatment (2009-08-25),
3. 7452901 - Anti-cancer phosphonate analogs (2008-11-18),
4. 7407965 - Phosphonate analogs for treating metabolic diseases (2008-08-05),
5. 6034118 - Thiepane compounds (2000-03-07),
6. 5811450 - Thiepane compounds (1998-09-22),
7. 5705524 - Thiepane compounds (1998-01-06),

Title: Innovations of Steven H Krawczyk

Introduction

Steven H Krawczyk is a notable inventor based in San Carlos, California. He has made significant contributions to the field of therapeutic agents, holding a total of seven patents. His work focuses on developing innovative compounds that address critical health issues.

Latest Patents

Among his latest patents is the invention of therapeutic phosphonate compounds. This invention relates to phosphorus substituted therapeutic agents, compositions containing these agents, and therapeutic methods for their administration. Additionally, he has developed nucleobase phosphonate analogs for antiviral treatment. These compounds are designed to combat infectious diseases by inhibiting retroviral reverse transcriptases, thereby preventing the replication of viruses such as HIV and HTLV.

Career Highlights

Steven Krawczyk has established a successful career at Gilead Sciences, Inc., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing treatments for serious viral infections.

Collaborations

He has collaborated with notable colleagues, including Choung U Kim and James Ming Chen, contributing to the development of groundbreaking therapeutic solutions.

Conclusion

Steven H Krawczyk's contributions to the field of therapeutic agents highlight his commitment to improving health outcomes through innovation. His patents reflect a dedication to addressing significant medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…